1. Mendelian randomization study of the relationship between blood and urine biomarkers and lung cancer
   Haihua Huang et al, 2024, Frontiers in Oncology CrossRef
2. Allometric fat mass index and alanine aminotransferase attenuate the associations of platelet parameters with lung cancer risk
   Sofia Christakoudi et al, 2024, Scientific Reports CrossRef
3. Relationship between the combination of platelet count and neutrophil‐lymphocyte ratio and prognosis of patients with advanced non‐small cell lung cancer treated with immune checkpoint inhibitors plus chemotherapy: A retrospective cohort study
   Saeko Kashimura et al, 2024, Thoracic Cancer CrossRef
4. Clinical role of pretreatment albumin-to-alkaline phosphatase ratio in lung cancer: a meta-analysis
   Yanhui Yang et al, 2024, Scientific Reports CrossRef
5. Immunotherapy targeting PD‑1/PD‑L1: A potential approach for the treatment of cancer bone metastases (Review)
   Toru Hiraga, 2024, International Journal of Oncology CrossRef
6. Can blood-based markers predict RECIST progression in non-small cell lung cancer treated with immunotherapy?
   Melda Yeghaian et al, 2024, Journal of Cancer Research and Clinical Oncology CrossRef